INTRODUCTION: Endothelial dysfunction, characterized by the loss of nitric oxide bioavailability, is a key element in the pathogenesis of atherosclerosis and an important prognostic factor in cardiovascular diseases. Therefore, the development of reliable, safe, and noninvasive methods of endothelial function assessment is important for their use in cardiovascular risk stratification. Brachial artery flow‑mediated dilation (FMD) is widely used in research but technical difficulties and problems with calibration between laboratories limit its clinical use. Reactive hyperemia-peripheral artery tonometry (RH‑PAT, EndoPAT) has been developed as a simpler, cheaper, and potentially more reproducible method. OBJECTIVES: We aimed to investigate associations between RH‑PAT and FMD in relation to atherosclerotic risk factor profile. PATIENTS AND METHODS: The study involved 80 subjects (52 men, 28 women) aged 43.6 ±14.8 years, with moderate‑to‑low cardiovascular risk (mean SCORE, 2.2% ±2%), in whom FMD, RH‑PAT, and intima-media thickness (IMT) were determined. RESULTS: The reactive hyperemia index (RHI) measured by RH‑PAT correlated with FMD (r = 0.35, P <0.01). However, no significant correlation was observed between RHI and IMT, SCORE, or the number of classical atherosclerotic risk factors (hypertension, smoking, diabetes, hypercholesterolemia), while FMD was significantly correlated with IMT (r = -0.53, P <0.001), risk factors (r = -0.55, P <0.05), and SCORE (r = -0.4, P <0.05). CONCLUSIONS: Despite its technical requirements, FMD is a more sensitive method than RH‑PAT in evaluating the effect of classical atherosclerotic risk factors on vascular endothelial function. Microvasculature response during RH‑PAT needs to be further studied, including the assessment of nonendothelial factors that may affect the measurements, before RH‑PAT becomes the universal tool for the evaluation of the endothelial cells.
INTRODUCTION: Endothelial dysfunction, characterized by the loss of nitric oxide bioavailability, is a key element in the pathogenesis of atherosclerosis and an important prognostic factor in cardiovascular diseases. Therefore, the development of reliable, safe, and noninvasive methods of endothelial function assessment is important for their use in cardiovascular risk stratification. Brachial artery flow‑mediated dilation (FMD) is widely used in research but technical difficulties and problems with calibration between laboratories limit its clinical use. Reactive hyperemia-peripheral artery tonometry (RH‑PAT, EndoPAT) has been developed as a simpler, cheaper, and potentially more reproducible method. OBJECTIVES: We aimed to investigate associations between RH‑PAT and FMD in relation to atherosclerotic risk factor profile. PATIENTS AND METHODS: The study involved 80 subjects (52 men, 28 women) aged 43.6 ±14.8 years, with moderate‑to‑low cardiovascular risk (mean SCORE, 2.2% ±2%), in whom FMD, RH‑PAT, and intima-media thickness (IMT) were determined. RESULTS: The reactive hyperemia index (RHI) measured by RH‑PAT correlated with FMD (r = 0.35, P <0.01). However, no significant correlation was observed between RHI and IMT, SCORE, or the number of classical atherosclerotic risk factors (hypertension, smoking, diabetes, hypercholesterolemia), while FMD was significantly correlated with IMT (r = -0.53, P <0.001), risk factors (r = -0.55, P <0.05), and SCORE (r = -0.4, P <0.05). CONCLUSIONS: Despite its technical requirements, FMD is a more sensitive method than RH‑PAT in evaluating the effect of classical atherosclerotic risk factors on vascular endothelial function. Microvasculature response during RH‑PAT needs to be further studied, including the assessment of nonendothelial factors that may affect the measurements, before RH‑PAT becomes the universal tool for the evaluation of the endothelial cells.
Authors: Flávia Almeida Santos; Karine Maria Martins Bezerra Carvalho; Francisco José Batista-Lima; Paulo Iury Gomes Nunes; Ana Flávia Seraine Custódio Viana; Armenio André de Carvalho Almeida da Silva; Said Gonçalves da Cruz Fonseca; Mariana Helena Chaves; Vietla Satyanarayana Rao; Pedro Jorge Caldas Magalhães; Teresinha Silva de Brito Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2017-07-17 Impact factor: 3.000
Authors: Tomas Kovarnik; Stepan Jerabek; Zhi Chen; Andreas Wahle; Ling Zhang; Gabriela Dostalova; Hana Skalicka; Ales Kral; Jan Horak; Milan Sonka; Ales Linhart Journal: Kardiol Pol Date: 2016-05-10 Impact factor: 3.108
Authors: Justin D Sprick; Kevin Mammino; Jinhee Jeong; Dana R DaCosta; Yingtian Hu; Doree G Morison; Joe R Nocera; Jeanie Park Journal: J Appl Physiol (1985) Date: 2022-02-10
Authors: T P Mikołajczyk; G Osmenda; B Batko; G Wilk; M Krezelok; D Skiba; T Sliwa; J R Pryjma; T J Guzik Journal: Lupus Date: 2015-08-06 Impact factor: 2.911
Authors: Rebekka Faber; Mette Zander; Adam Pena; Marie M Michelsen; Naja D Mygind; Eva Prescott Journal: Cardiovasc Diabetol Date: 2015-04-22 Impact factor: 9.951
Authors: Joanna Maciąg; Grzegorz Osmenda; Daniel Nowakowski; Grzegorz Wilk; Anna Maciąg; Tomasz Mikołajczyk; Ryszard Nosalski; Agnieszka Sagan; Magdalena Filip; Mirosław Dróżdż; Jolanta Loster; Tomasz J Guzik; Marta Cześnikiewicz-Guzik Journal: Biomed Res Int Date: 2014-06-19 Impact factor: 3.411
Authors: Pawel P Wolkow; Wladyslaw Kosiniak-Kamysz; Grzegorz Osmenda; Grzegorz Wilk; Beata Bujak-Gizycka; Adam Ignacak; Mihir Kanitkar; Malgorzata Walus-Miarka; David G Harrison; Ryszard Korbut; Maciej T Malecki; Tomasz J Guzik Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240
Authors: Jessika M Lobraico; Lauren C DiLello; Amber D Butler; Marie Elena Cordisco; Joann R Petrini; Ramin Ahmadi Journal: BMJ Open Diabetes Res Care Date: 2015-10-14